A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis

Xiu-Qi Chen1, Lin-Lin Wang, Qing-Wen Shan

  • 1Department of Pediatrics, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi, China.

Insights

A novel NR1H4 gene mutation (R176X) was identified in one infant with idiopathic infantile cholestasis. This genetic finding aids in diagnosing and understanding the prognosis of this liver disease in infants.

Area of Science:

  • Genetics
  • Pediatric Hepatology
  • Molecular Biology

Background:

  • Idiopathic infantile cholestasis (IIC) is a serious liver condition in infants.
  • Genetic factors are implicated in IIC pathogenesis.
  • The NR1H4 gene's role in IIC requires further investigation.

Purpose of the Study:

  • To investigate the genetic contribution of the NR1H4 gene to the development of IIC.
  • To identify potential genetic markers for IIC in a Chinese population.

Main Methods:

  • Genomic DNA was extracted from 78 IIC patients and 95 controls.
  • Polymerase chain reaction (PCR) and single-strand conformation polymorphism (SSCP) were used to analyze NR1H4 gene exons.
  • PCR products with abnormal bands were sequenced.

Main Results:

  • A novel heterozygous termination codon mutation, NR1H4 R176X (CGA-TGA), was identified in one IIC patient.
  • The patient with the R176X mutation exhibited severe liver dysfunction, including high bilirubin, ALT, GGT, cirrhosis, and ascites.
  • No NR1H4 mutations were detected in other patients or controls.

Conclusions:

  • A heterozygous termination codon mutation in NR1H4 (R176X) is associated with IIC.
  • This novel mutation provides a characteristic marker for differential diagnosis of IIC.
  • The NR1H4 R176X mutation may influence the prognosis of IIC.
Abstract

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations01:39

Mutations

Overview
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...